Genenta Science S.p.A. (SAEN) income statement
SAENNasdaqBiological Products, (No Diagnostic Substances)
$0.58−0.02 (-3.83%)
Close on Nov 17, 2026Market cap $13.52MP/E –Yield –
Genenta Science S.p.A. income statement
Ratios
Latest available, balances at Dec 31, 2025
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2025
- -38.0%
Financial strength
- Current ratio
- 14.16
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 261.0%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 0.56
- Dividend yield
- –
See a number that looks wrong?